Jung, T.;                     Haist, M.;                     Kuske, M.;                     Grabbe, S.;                     Bros, M.    
        Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy—Paradoxical ERK Activation and Beyond. Int. J. Mol. Sci. 2021, 22, 9890.
    https://doi.org/10.3390/ijms22189890
    AMA Style
    
                                Jung T,                                 Haist M,                                 Kuske M,                                 Grabbe S,                                 Bros M.        
                Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy—Paradoxical ERK Activation and Beyond. International Journal of Molecular Sciences. 2021; 22(18):9890.
        https://doi.org/10.3390/ijms22189890
    
    Chicago/Turabian Style
    
                                Jung, Thomas,                                 Maximilian Haist,                                 Michael Kuske,                                 Stephan Grabbe,                                 and Matthias Bros.        
                2021. "Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy—Paradoxical ERK Activation and Beyond" International Journal of Molecular Sciences 22, no. 18: 9890.
        https://doi.org/10.3390/ijms22189890
    
    APA Style
    
                                Jung, T.,                                 Haist, M.,                                 Kuske, M.,                                 Grabbe, S.,                                 & Bros, M.        
        
        (2021). Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy—Paradoxical ERK Activation and Beyond. International Journal of Molecular Sciences, 22(18), 9890.
        https://doi.org/10.3390/ijms22189890